Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Quick Stats
Jan 30, 202657.9
AI Score
HOLD1.06
Volume Ratio
Feb 26, 2026
Next Earnings
13
+ve Days (30d)
15
-ve Days (30d)
ALT Stock Summary
Last updated Jan 30, 2026
ALT is currently trading at $5.6, positioned above its 200-day moving average of $4.55, indicating a long-term uptrend. The stock has a 52-week range of $2.9 to $7.73.
Technical Analysis: The 50-day moving average stands at $4.7, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 61.381, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.146, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ALT at 57.9/100 with a HOLD recommendation.
ALT (Altimmune, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 61.381 |
| CMF (20) | -0.146 |
| ROC (10) | 30.896 |
| ADX (14) | 31.825 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.314 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -35.885 |
| MFI (14) | 59.89 |
ALT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ALT Price vs Max Options Open Interest
ALT Max Change In Options Open Interest
ALT Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ALT Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ALT Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ALT Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Altimmune, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
ALT Moving Averages Analysis
Altimmune, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Altimmune, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
ALT (Altimmune, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 5.16 |
| 20 | 4.6 |
| 30 | 4.43 |
| 50 | 4.7 |
| 100 | 4.32 |
| 200 | 4.55 |
ALT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 534.2 million |
| Earnings/Share ($) | -1.07 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.9774 |
| EPS Estimate Next Year ($) | -1.2449 |
| WallStreet Target Price ($) | 17.6667 |
| Most Recent Quarter |
News Summary: $ALT stock sees significant increase in volume and ownership by Vanguard, with a new investor taking a 14% stake. The company announces a direct offering of shares and pre-funded warrants, indicating potential undervaluation or positive direction. The stock opens bullish despite expectations of a red day. France is welcomed as a new investor.
Updated 2026-01-30 17:00:01